US 8741880
Antiglucocorticoid therapy for the prevention of neurological damage in premature infants
granted A61KA61K31/56A61K31/567
Quick answer
US patent 8741880 (Antiglucocorticoid therapy for the prevention of neurological damage in premature infants) held by Corcept Therapeutics Incorporated expires Mon May 29 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Corcept Therapeutics Incorporated
- Grant date
- Tue Jun 03 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 29 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K31/56, A61K31/567, A61K31/569, A61K31/573